<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35207171</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">898</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11040898</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID has become a burden on healthcare systems worldwide. Research into the etiology and risk factors has been impeded by observing all diverse manifestations as part of a single entity. We aimed to determine patterns of symptoms in convalescing COVID-19 patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Symptomatic patients were recruited from four countries. Data were collected regarding demographics, comorbidities, acute disease and persistent symptoms. Factor analysis was performed to elucidate symptom patterns. Associations of the patterns with patients' characteristics, features of acute disease and effect on daily life were sought.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 1027 symptomatic post-COVID individuals in the analysis. The majority of participants were graded as having a non-severe acute COVID-19 (N = 763, 74.3%). We identified six patterns of symptoms: cognitive, pain-syndrome, pulmonary, cardiac, anosmia-dysgeusia and headache. The cognitive pattern was the major symptoms pattern, explaining 26.2% of the variance; the other patterns each explained 6.5-9.5% of the variance. The cognitive pattern was higher in patients who were outpatients during the acute disease. The pain-syndrome pattern was associated with acute disease severity, higher in women and increased with age. The pulmonary pattern was associated with prior lung disease and severe acute disease. Only two of the patterns (cognitive and cardiac) were associated with failure to return to pre-COVID occupational and physical activity status.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Long COVID diverse symptoms can be grouped into six unique patterns. Using these patterns in future research may improve our understanding of pathophysiology and risk factors of persistent COVID, provide homogenous terminology for clinical research, and direct therapeutic interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yelin</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 6910203, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margalit</LastName><ForeName>Ili</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2622-418X</Identifier><AffiliationInfo><Affiliation>COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 6910203, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nehme</LastName><ForeName>Mayssam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division and Department of Primary Care Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bordas-Mart&#xed;nez</LastName><ForeName>Jaume</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4027-8907</Identifier><AffiliationInfo><Affiliation>Pulmonology Department, Bellvitge University Hospital, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Department, Bellvitge University Hospital, Institute for Biomedical Research (IDIBELL), University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5612-6364</Identifier><AffiliationInfo><Affiliation>Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pulmonary Unit, Cardiothoracic and Vascular Department, University Hospital, 56124 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahav</LastName><ForeName>Dafna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 6910203, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guessous</LastName><ForeName>Idris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division and Department of Primary Care Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dur&#xe0;-Miralles</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, 08003 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrozzi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Bellvitge University Hospital, Institute for Biomedical Research (IDIBELL), University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapira-Lichter</LastName><ForeName>Irit</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4734-7744</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 6910203, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Functional MRI Center, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vetter</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peleato-Catalan</LastName><ForeName>Dolores</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ramona via Primary Care Center, El Prat de Llobregat, 08820 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiseo</LastName><ForeName>Giusy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirtheim</LastName><ForeName>Eytan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Management, Rabin Medical Center, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudiol</LastName><ForeName>Carlota</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3095-4422</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Department, Bellvitge University Hospital, Institute for Biomedical Research (IDIBELL), University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, Hospital Duran y Reynals, Institut Catal&#xe0; d'Oncologia (ICO), IDIBELL, 08908 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 08003 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leibovici</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Authority, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>On Behalf Of The LongCOV Research Group</LastName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021</GrantID><Agency>Israeli Insurance Association research fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long lasting symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35207171</ArticleId><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="doi">10.3390/jcm11040898</ArticleId><ArticleId IdType="pii">jcm11040898</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella F., Tommasini A., Fabris M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C. Follow-up of adults with non-critical COVID-19 two months after symptoms&#x2019; onset. Clin. Microbiol. Infect. 2020;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C., Collins L.F., Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324:1723&#x2013;1724. doi: 10.1001/jama.2020.19719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Wirtheim E., Vetter P., Kalil A.C., Bruchfeld J., Runold M., Guaraldi G., Mussini C., Gudiol C., Pujol M., et al. Long-term consequences of COVID-19: Research needs. Lancet Infect. Dis. 2020;20:1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting. Ann. Intern. Med. 2021;174:1252&#x2013;1260. doi: 10.7326/M21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  WHO Interim Clinical Guidance May 27 2020.  [(accessed on 28 April 2021)].  Available online:  https://www.who.int/publications/i/item/clinical-management-of-covid-19.</Citation></Reference><Reference><Citation>Scoppettuolo P., Borrelli S., Naeije G. Neurological involvement in SARS-CoV-2 infection: A clinical systematic review. Brain Behav. Immun. Health. 2020;5:100094. doi: 10.1016/j.bbih.2020.100094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100094</ArticleId><ArticleId IdType="pmc">PMC7832728</ArticleId><ArticleId IdType="pubmed">33521692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Li J., Liu H., Han N., Ju J., Kou Y., Chen L., Jiang M., Pan F., Zheng Y., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.A., Lee K.S., Primack S.L., Yoon H.K., Byun H.S., Kim T.S., Suh G.Y., Kwon O.J., Han J. Viral Pneumonias in Adults: Radiologic and Pathologic Findings. RadioGraphics. 2002;22:S137&#x2013;S149. doi: 10.1148/radiographics.22.suppl_1.g02oc15s137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiographics.22.suppl_1.g02oc15s137</ArticleId><ArticleId IdType="pubmed">12376607</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeld K.J., Leoutsakos J.-M.S., Yan H., Lin S., Zabinski J.S., Dinglas V.D., Hosey M.M., Parker A.M., Hopkins R.O., Needham D.M. Fatigue Symptoms During the First Year Following ARDS. Chest. 2020;158:999&#x2013;1007. doi: 10.1016/j.chest.2020.03.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.03.059</ArticleId><ArticleId IdType="pmc">PMC7478232</ArticleId><ArticleId IdType="pubmed">32304774</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S.C., Wong K.T., Antonio G.E., Tong M., Chan D.P., Sung J.J.Y. Long-term sequelae of SARS: Physical, neuropsychiatric, and quality-of-life assessment. Hong Kong Med. J. 2009;15:21&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20393208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H.-B., Wing Y.-K., Yu M.W.-M., Leung C.-M., Ma R.C.W., Kong A.P.S., So W., Fong S.Y.-Y., Lam S.-P. Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors: Long-term Follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollm&#xe4;cher T. Cytokine-Associated Emotional and Cognitive Disturbances in Humans. Arch. Gen. Psychiatry. 2001;58:445&#x2013;452. doi: 10.1001/archpsyc.58.5.445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.58.5.445</ArticleId><ArticleId IdType="pubmed">11343523</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramovitch A., McCormack B., Brunner D., Johnson M., Wofford N. The impact of symptom severity on cognitive function in obsessive-compulsive disorder: A meta-analysis. Clin. Psychol. Rev. 2018;67:36&#x2013;44. doi: 10.1016/j.cpr.2018.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2018.09.003</ArticleId><ArticleId IdType="pubmed">30528984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., Reeves W.C., Lloyd A. Post infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ. 2006;333:575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D., Ashley R.L., Pearlman T., Kith P., Komaroff A.L. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J. Med. Virol. 1996;50:25&#x2013;30. doi: 10.1002/(SICI)1096-9071(199609)50:1&lt;25::AID-JMV6&gt;3.0.CO;2-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199609)50:1&lt;25::AID-JMV6&gt;3.0.CO;2-V</ArticleId><ArticleId IdType="pubmed">8890037</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M., Klingel K., Kindermann I., Brucato A., De Rosa F.G., Adler Y., De Ferrari G.M. COVID-19 pandemic and troponin: Indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020;106:1127&#x2013;1131. doi: 10.1136/heartjnl-2020-317186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317186</ArticleId><ArticleId IdType="pubmed">32499236</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J., Wong L.-Y.R., Li K., Verma A.K., Ortiz M.E., Wohlford-Lenane C., Leidinger M.R., Knudson C.M., Meyerholz D.K., McCray P.B., Jr., et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589:603&#x2013;607. doi: 10.1038/s41586-020-2943-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2943-z</ArticleId><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L., Shmueli E., Ehrlich S., Ziv A., Bar-On O., Birk E., Lowenthal A., Prais D. Long COVID in Children: Observations from a Designated Pediatric Clinic. Pediatr. Infect. Dis. J. 2021;40:e509&#x2013;e511. doi: 10.1097/INF.0000000000003285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>